Cargando…
Progress in adjuvant chemotherapy for breast cancer: an overview
Breast cancer is the most common cause of cancer and cancer death worldwide. Although most patients present with localized breast cancer and may be rendered disease-free with local therapy, distant recurrence is common and is the primary cause of death from the disease. Adjuvant systemic therapies a...
Autores principales: | Anampa, Jesus, Makower, Della, Sparano, Joseph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538915/ https://www.ncbi.nlm.nih.gov/pubmed/26278220 http://dx.doi.org/10.1186/s12916-015-0439-8 |
Ejemplares similares
-
The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes
por: Barbi, Mali, et al.
Publicado: (2021) -
Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer
por: Makower, Della, et al.
Publicado: (2021) -
The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis
por: Makower, Della, et al.
Publicado: (2022) -
An interactive mobile application versus an educational booklet to promote job retention in women undergoing adjuvant chemotherapy for breast cancer: a randomized controlled trial
por: Blinder, Victoria S., et al.
Publicado: (2022) -
Update on Adjuvant Chemotherapy for Early Breast Cancer
por: Rampurwala, Murtuza M, et al.
Publicado: (2014)